FDA hits a green light on 2 more rare dis­ease drugs, giv­ing Alex­ion an ear­ly shot at pro­tect­ing PNH fran­chise

Faced with the prospect of a par­tial gov­ern­ment shut­down lat­er to­day, the FDA has pulled the trig­ger on a pair of new drug ap­provals. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.